Phase II trial of biweekly gemcitabine, paclitaxel, and bevacizumab as frontline therapy for metastatic breast cancer (MBC)

Abstract only

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 29; no. 15_suppl; p. e11527
Main Authors:	Nahleh, Z. A., Gupta, R., Abrams, J., Gartner, E. M., Reichle, L.
Format:	Journal Article
Language:	English
Published:	20-05-2011
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!